LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway
- PMID: 33829423
- DOI: 10.26355/eurrev_202103_25398
LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway
Abstract
The article "LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway, by Y. Lei, Y.-H. Wang, X.-F. Wang, J. Bai, published in Eur Rev Med Pharmacol Sci 2018; 22 (19): 6315-6323-DOI: 10.26355/eurrev_201810_16042-PMID: 30338799" has been withdrawn from the authors due to inaccuracies and mistakes throughout the paper. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/16042.
Retraction of
-
LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway.Eur Rev Med Pharmacol Sci. 2018 Oct;22(19):6315-6323. doi: 10.26355/eurrev_201810_16042. Eur Rev Med Pharmacol Sci. 2018. Retraction in: Eur Rev Med Pharmacol Sci. 2021 Mar;25(6):2460. doi: 10.26355/eurrev_202103_25398. PMID: 30338799 Retracted.
Similar articles
-
FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway.Eur Rev Med Pharmacol Sci. 2021 Mar;25(5):2159. doi: 10.26355/eurrev_202103_25247. Eur Rev Med Pharmacol Sci. 2021. PMID: 33755958
-
MicroRNA-191-5p promotes the development of osteosarcoma via targeting EGR1 and activating the PI3K/AKT signaling pathway.Eur Rev Med Pharmacol Sci. 2021 Apr;25(8):3145. doi: 10.26355/eurrev_202104_25706. Eur Rev Med Pharmacol Sci. 2021. PMID: 33928592
-
LncRNA PAPAS aggravates the progression of gastric cancer through regulating miRNA-188-5p.Eur Rev Med Pharmacol Sci. 2021 Mar;25(6):2462. doi: 10.26355/eurrev_202103_25402. Eur Rev Med Pharmacol Sci. 2021. PMID: 33829425
-
Circ_0061140 promotes metastasis of bladder cancer through adsorbing microRNA-1236.Eur Rev Med Pharmacol Sci. 2021 Mar;25(5):2157. doi: 10.26355/eurrev_202103_25199. Eur Rev Med Pharmacol Sci. 2021. PMID: 33755946
-
MiR-124 affects the apoptosis of brain vascular endothelial cells and ROS production through regulating PI3K/AKT signaling pathway.Eur Rev Med Pharmacol Sci. 2021 Jul;25(14):4647. doi: 10.26355/eurrev_202107_26368. Eur Rev Med Pharmacol Sci. 2021. PMID: 34337709
Cited by
-
Interplay between lncRNAs and the PI3K/AKT signaling pathway in the progression of digestive system neoplasms (Review).Int J Mol Med. 2025 Jan;55(1):15. doi: 10.3892/ijmm.2024.5456. Epub 2024 Nov 8. Int J Mol Med. 2025. PMID: 39513614 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources